Cronos Group (TSE:CRON) Shares Down 1.4% - Here's Why

Key Points

• Cronos Group Inc. shares fell 1.4% to C$3.43, with trading volume down 47% from its average.
• The company has a market capitalization of C$1.31 billion and maintains a high price-to-earnings ratio of 68.60.
• Cronos operates primarily in Canada but also exports medicinal cannabis to Poland and Germany, with joint ventures in several other countries.

Cronos Group Inc. (TSE:CRON - Get Free Report) shares dropped 1.4% during trading on Monday . The company traded as low as C$3.41 and last traded at C$3.43. Approximately 101,000 shares traded hands during mid-day trading, a decline of 47% from the average daily volume of 188,844 shares. The stock had previously closed at C$3.48.

Cronos Group Stock Performance

The firm has a market cap of C$1.34 billion, a price-to-earnings ratio of 69.80, a price-to-earnings-growth ratio of 0.12 and a beta of 1.21. The stock's 50 day moving average is C$3.17 and its 200 day moving average is C$2.83. The company has a current ratio of 24.24, a quick ratio of 24.01 and a debt-to-equity ratio of 0.17.

Cronos Group Company Profile

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth.